Deep neural network or dermatologist?

Deep learning techniques have proven high accuracy for identifying melanoma in digitised dermoscopic images. A strength is that these methods are not constrained by features that are pre-defined by human semantics. A down-side is that it is difficult to understand the rationale of the model predictions and to identify potential failure modes. This is a major barrier to adoption of deep learning in clinical practice. In this paper we ask if two existing local interpretability methods, Grad-CAM and Kernel SHAP, can shed light on convolutional neural networks trained in the context of melanoma detection. Our contributions are (i) we first explore the domain space via a reproducible, end-to-end learning framework that creates a suite of 30 models, all trained on a publicly available data set (HAM10000), (ii) we next explore the reliability of GradCAM and Kernel SHAP in this context via some basic sanity check experiments (iii) finally, we investigate a random selection of models from our suite using GradCAM and Kernel SHAP. We show that despite high accuracy, the models will occasionally assign importance to features that are not relevant to the diagnostic task. We also show that models of similar accuracy will produce different explanations as measured by these methods. This work represents first steps in bridging the gap between model accuracy and interpretability in the domain of skin cancer classification

Position statement of the EADV Artificial Intelligence (AI) Task Force on AI‐assisted smartphone apps and web‐based services for skin disease

Background: As the use of smartphones continues to surge globally, mobile applications (apps) have become a powerful tool for healthcare engagement. Prominent among these are dermatology apps powered by Artificial Intelligence (AI), which provide immediate diagnostic guidance and educational resources for skin diseases, including skin cancer. Objective: This article, authored by the EADV AI Task Force, seeks to offer insights and recommendations for the present and future deployment of AI‐assisted smartphone applications (apps) and web‐based services for skin diseases with emphasis on skin cancer detection.MethodsAn initial position statement was drafted on a comprehensive literature review, which was subsequently refined through two rounds of digital discussions and meticulous feedback by the EADV AI Task Force, ensuring its accuracy, clarity and relevance. Results: Eight key considerations were identified, including risks associated with inaccuracy and improper user education, a decline in professional skills, the influence of non‐medical commercial interests, data security, direct and indirect costs, regulatory approval and the necessity of multidisciplinary implementation. Following these considerations, three main recommendations were formulated: (1) to ensure user trust, app developers should prioritize transparency in data quality, accuracy, intended use, privacy and costs; (2) Apps and web‐based services should ensure a uniform user experience for diverse groups of patients; (3) European authorities should adopt a rigorous and consistent regulatory framework for dermatology apps to ensure their safety and accuracy for users. Conclusions: The utilisation of AI‐assisted smartphone apps and web‐based services in diagnosing and treating skin diseases has the potential to greatly benefit patients in their dermatology journeys. By prioritising innovation, fostering collaboration and implementing effective regulations, we can ensure the successful integration of these apps into clinical practice

Theopolis Monk: Envisioning a Future of A.I. Public Service

Visions of future applications of artificial intelligence tend to veer toward the naively optimistic or frighteningly dystopian, neglecting the numerous human factors necessarily involved in the design, deployment and oversight of such systems. The dream that AI systems may somehow replace the irregularities and struggles of human governance with unbiased efficiency is seen to be non-scientific and akin to a religious hope, whereas the current trajectory of AI development indicates that it will increasingly serve as a tool by which humans exercise control over other humans. To facilitate the responsible development of AI systems for the public good, we discuss current conversations on the topics of transparency and accountability

K\ufcnstliche Intelligenz und Smartphone-Programm-Applikationen (Apps): Bedeutung f\ufcr die dermatologische Praxis

Advantages of artificial intelligence (AI): With responsible, safe and successful use of artificial intelligence (AI), possible advantages in the field of dermato-oncology include the following: (1) medical work can focus on skin cancer patients, (2) patients can be more quickly and effectively treated despite the increasing incidence of skin cancer and the decreasing number of actively working dermatologists and (3) users can learn from the AI results. Potential disadvantages and risks of AI use: (1) Lack of mutual trust can develop due to the decreased patient\u2013physician contact, (2) additional time effort will be necessary to promptly evaluate the AI-classified benign lesions, (3) lack of adequate medical experience to recognize misclassified AI decisions and (4) recontacting a patient in due time in the case of incorrect AI classifications. Still problematic in the use of AI are the medicolegal situation and remuneration. Apps using AI currently cannot provide sufficient assistance based on clinical images of skin cancer. Requirements and possible use of smartphone program applications: Smartphone program applications (apps) can be implemented responsibly when the image quality is good, the patient\u2019s history can be entered easily, transmission of the image and results are assured and medicolegal aspects as well as remuneration are clarified. Apps can be used for disease-specific information material and can optimize patient care by using teledermatology

[Dermoscopy of nails]

Pigmented and nonpigmented nail abnormalities often represent a challenge for clinicians because many, and sometimes potentially life-threatening differential diagnoses must be taken into consideration. Although many details of nail diseases can already be assessed with the naked eye, dermoscopy opens up a second microscopic level of inspection, which can be very useful for the diagnostic process. In the last 20 years dermoscopy has made rapid progress in the further development of criteria for the early recognition of melanoma. In addition, the use of dermoscopy has been extended to the examination of cutaneous adnexa, such as hairs (trichoscopy) and nails (onychoscopy). Many, sometimes highly specific criteria for the dermoscopic assessment of nail diseases have been described in a series of recently published articles. This review article provides important diagnostic aids for a well-founded dermoscopic assessment of nail diseases